» Articles » PMID: 19787776

Modeling G Protein-coupled Receptors for Structure-based Drug Discovery Using Low-frequency Normal Modes for Refinement of Homology Models: Application to H3 Antagonists

Overview
Journal Proteins
Date 2009 Sep 30
PMID 19787776
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

G Protein-Coupled Receptors (GPCRs) are integral membrane proteins that play important role in regulating key physiological functions, and are targets of about 50% of all recently launched drugs. High-resolution experimental structures are available only for very few GPCRs. As a result, structure-based drug design efforts for GPCRs continue to rely on in silico modeling, which is considered to be an extremely difficult task especially for these receptors. Here, we describe Gmodel, a novel approach for building 3D atomic models of GPCRs using a normal mode-based refinement of homology models. Gmodel uses a small set of relevant low-frequency vibrational modes derived from Random Elastic Network model to efficiently sample the large-scale receptor conformation changes and generate an ensemble of alternative models. These are used to assemble receptor-ligand complexes by docking a known active into each of the alternative models. Each of these is next filtered using restraints derived from known mutation and binding affinity data and is refined in the presence of the active ligand. In this study, Gmodel was applied to generate models of the antagonist form of histamine 3 (H3) receptor. The validity of this novel modeling approach is demonstrated by performing virtual screening (using the refined models) that consistently produces highly enriched hit lists. The models are further validated by analyzing the available SAR related to classical H3 antagonists, and are found to be in good agreement with the available experimental data, thus providing novel insights into the receptor-ligand interactions.

Citing Articles

Dual Piperidine-Based Histamine H and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain.

Szczepanska K, Karcz T, Dichiara M, Mogilski S, Kalinowska-Tluscik J, Pilarski B J Med Chem. 2023; 66(14):9658-9683.

PMID: 37418295 PMC: 10388327. DOI: 10.1021/acs.jmedchem.3c00430.


A unique ligand-steered strategy for CC chemokine receptor 2 homology modeling to facilitate structure-based virtual screening.

Jin H, Xia J, Liu Z, Wang X, Zhang L Chem Biol Drug Des. 2021; 97(4):944-961.

PMID: 33386704 PMC: 8048943. DOI: 10.1111/cbdd.13820.


Synthesis and Characterization of a Bidirectional Photoswitchable Antagonist Toolbox for Real-Time GPCR Photopharmacology.

Hauwert N, Mocking T, da Costa Pereira D, Kooistra A, Wijnen L, Vreeker G J Am Chem Soc. 2018; 140(12):4232-4243.

PMID: 29470065 PMC: 5879491. DOI: 10.1021/jacs.7b11422.


Hybrid approach to structure modeling of the histamine H3 receptor: Multi-level assessment as a tool for model verification.

Jonczyk J, Malawska B, Bajda M PLoS One. 2017; 12(10):e0186108.

PMID: 28982153 PMC: 5629032. DOI: 10.1371/journal.pone.0186108.


Structure-Encoded Global Motions and Their Role in Mediating Protein-Substrate Interactions.

Bahar I, Cheng M, Lee J, Kaya C, Zhang S Biophys J. 2015; 109(6):1101-9.

PMID: 26143655 PMC: 4576147. DOI: 10.1016/j.bpj.2015.06.004.